An agency of the National Institutes of Health has awarded funding up to $7 million to researchers at the University…
Articles by Andrea Lobo, PhD
Lung function decline slowed consistently over five years with Kalydeco (ivacaftor) treatment in adults and children with cystic…
More severe lung disease and using inhaled corticosteroids are associated with shorter telomere length, a sign of cellular aging, in…
Most people with cystic fibrosis (CF) who carry mutations that make them ineligible for CFTR modulators are prescribed medications…
Having COVID-19 had no clinically meaningful impact on lung function and nutritional status for people with cystic fibrosis in…
The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial testing ARCT-032, an inhaled therapy candidate,…
A report described episodes of skin rash associated with joint pain and inflammation, known as dermatitis-arthritis syndrome, in four females…
A researcher at the University of California, Los Angeles (UCLA) has been awarded the Elizabeth Nash Postdoctoral Fellowship to…
Treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) may ease anxiety and depression symptoms in adults with cystic fibrosis (CF), a study…
Most infants with cystic fibrosis (CF) must be fed fortified milk, that is, breast milk, formula, or a combination…